Skip to main navigation

Menu

About RedHill

Company Profile
Management Team
Board of Directors
Advisory Board

Products

Commercial Products
- Donnatal®
- EnteraGam®
Development Pipeline

Investors

PRESS RELEASES
EVENTS & PRESENTATIONS
SEC FILINGS AND FINANCIAL INFORMATION
STOCK INFORMATION
ANALYST INFORMATION
CORPORATE GOVERNANCE
CONTACT US

News

2018
2017
2016
2015
2014
2013

Home // Investors

Investors

PRESS RELEASES

Summary Toggle RedHill Biopharma Announces Closing of $20 Million Underwritten Offering

Dec 11, 2018

PDF Version
Summary Toggle RedHill Biopharma Announces Pricing of $20 Million Underwritten Offering

Dec 6, 2018

PDF Version

CORPORATE PRESENTATION

RedHill Biopharma TALICIA Confirmatory Phase III Results Webcast 1.4 MB

Dec 03, 2018

UPCOMING EVENTS & PRESENTATIONS

More events are coming soon.

FEATURED EVENTS

BMO 2018 Prescriptions for Success Healthcare Conference

Dec 12, 2018

Location:

Mandarin Oriental, New York

Listen to webcast

View Additional Information

RedHill's presentation:

Date: Wednesday, Dec 12, 2018
Time: 3:00 PM ET
Room: NORTH SALON I

TALICIA Confirmatory Phase III Top-Line Results Webcast

Dec 3, 2018
8:30 AM EST

Listen to webcast

RedHill Biopharma TALICIA Confirmatory Phase III Results Webcast 1.4 MB

Investor Relations

Press Releases
Events & Presentations
SEC Filings and Financial Information
Stock Information
Analyst Information
Corporate Governance
Contact Us

Investor Tools

Email Alerts Subscription
Download Library
Snapshot
RSS News Feeds
Print
Share

Facebook
Google
LinkedIn
Twitter
RSS

Home | Site menu | Privacy & Terms

Copyright © All Rights Reserved for RedHill Biopharma Ltd.
Created by Catom web design